MLchartDataset catalogue

CEP-701

Term · Oncology and biomedicine · MLC-T-ONC-001587

A drug being studied in the treatment of acute leukemias and some other types of cancer. It binds to a protein that is present on the surface of some types of cancer cells and stops them from dividing. CEP-701 is a type of receptor tyrosine kinase inhibitor and a type of indolocarbazole alkaloid. Also called lestaurtinib.

Table 1. Record
IdentifierMLC-T-ONC-001587
FieldOncology and biomedicine
Expansionslestaurtinib
ReferencesNCI Dictionary of Cancer Terms
Record as JSON 
{
  "id": "MLC-T-ONC-001587",
  "term": "CEP-701",
  "field": "Oncology and biomedicine",
  "definition": "A drug being studied in the treatment of acute leukemias and some other types of cancer. It binds to a protein that is present on the surface of some types of cancer cells and stops them from dividing. CEP-701 is a type of receptor tyrosine kinase inhibitor and a type of indolocarbazole alkaloid. Also called lestaurtinib.",
  "expansions": [
    "lestaurtinib"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/cep-701/"
}

Record 4,595 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.